Pharmacokinetic drug interactions in liver disease: An update
about
Intrahepatic Sampling for the Elucidation of Antiviral Clinical Pharmacology.Assessment of Hepatic Impairment and Implications for Pharmacokinetics of Substance Use Treatment.Pregnane X receptor and constitutive androstane receptor modulate differently CYP3A-mediated metabolism in early- and late-stage cholestasis.Pentobarbital Removal During Continuous Venovenous Hemofiltration: Case Report and Review of the Literature.Alterations in the gene expression of drug and arachidonic acid-metabolizing Cyp450 in the livers of controlled and uncontrolled insulin-dependent diabetic mice
P2860
Pharmacokinetic drug interactions in liver disease: An update
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Pharmacokinetic drug interactions in liver disease: An update
@ast
Pharmacokinetic drug interactions in liver disease: An update
@en
Pharmacokinetic drug interactions in liver disease: An update
@nl
type
label
Pharmacokinetic drug interactions in liver disease: An update
@ast
Pharmacokinetic drug interactions in liver disease: An update
@en
Pharmacokinetic drug interactions in liver disease: An update
@nl
prefLabel
Pharmacokinetic drug interactions in liver disease: An update
@ast
Pharmacokinetic drug interactions in liver disease: An update
@en
Pharmacokinetic drug interactions in liver disease: An update
@nl
P2860
P356
P1476
Pharmacokinetic drug interactions in liver disease: An update
@en
P2093
Pietro Palatini
P2860
P304
P356
10.3748/WJG.V22.I3.1260
P407
P577
2016-01-21T00:00:00Z